Use casesNHS & Healthcare
Know which medicines need attention before stock becomes the problem.
See disruption earlier and support procurement and switching decisions. MedSupply Intelligence helps hospital pharmacy teams move from reactive shortage response to portfolio-level medicines management.
Who this is for
Hospital pharmacy procurement, medicines governance, clinical pharmacy and pharmacy leadership teams in NHS Trusts, and other healthcare organisations managing medicines supply.
The current reality
Shortages surface after the fact.
Hospital pharmacy teams usually learn about a supply problem when an order stays outstanding, a delivery lapses or a wholesaler confirms no resupply date.
By then the reactive cycle has started: chasing suppliers, seeking stock from other Trusts, escalating regionally and issuing internal bulletins.
Trusts are not asking for more data. They are asking for earlier decisions.
Pressure across the pharmacy operation
- Official notifications arrive at failed supply, not emerging risk
- Wholesalers give limited forward visibility
- Procurement chases manually across suppliers
- Governance pharmacists absorb shortage communications
- Daily backward checks on deliveries
- Weekly leadership shortage meetings driven by reactive pressure
- Clinical teams switch without preparation time
- No portfolio view of what needs attention this week
How MedSupply Intelligence helps
Earlier context, across the whole formulary.
MedSupply Intelligence brings supply, availability, pricing and active-ingredient pressure together around the medicines a Trust depends on, so procurement, governance and clinical teams can see what needs attention and prepare before stock becomes the problem.
Compare our productsSix decisions. Earlier context.
See emerging disruption earlierEarly warning
Official notifications tend to arrive at the point of failed supply, not emerging risk. Earlier context gives procurement and clinical teams time to prepare.
Supports
- Stock cover
- Escalation timing
- Internal communications
Prioritise which medicines need attention this weekPrioritisation
Replace a reactive list with a portfolio view: which medicines are under emerging pressure, and which are stable.
Supports
- Weekly shortage meetings
- Procurement focus
- Leadership reporting
Focus procurement effortProcurement
With earlier sight of where pressure is building, chasing and checking can be directed at the lines that need it rather than spread across every order.
Supports
- Supplier follow-up
- Alternative sourcing
- Mutual aid requests
Prepare switching decisionsClinical switching
Give clinical and formulary teams earlier notice of where alternatives may need to be reviewed, so switches are planned rather than forced.
Supports
- Formulary review
- Clinical guidance
- Prescriber communication
See active-ingredient pressure before products failMolecule risk
Pressure at the active-ingredient level is often invisible until individual products fail. Seeing it earlier widens the response window across affected presentations.
Supports
- Alternative presentation planning
- Risk assessment
Give governance and leadership a shared viewGovernance
Governance pharmacists, procurement, clinical teams and leadership work from the same evidence when a shortage crosses departmental lines.
Supports
- Governance communications
- Board and leadership reporting
- Regional escalation
MedSupply Intelligence brings together supply, availability, pricing and risk signals to give earlier visibility of emerging market pressure and changing conditions.
See where pressure is emerging on the medicines your Trust depends on.